Phylo and Chugai Partner for AI Drug Discovery

Phylo, Inc. and Chugai Pharmaceutical have partnered to integrate the Biomni Lab platform into drug discovery ^[1]. This agentic AI system aims to consolidate fragmented biomedical datasets ^[1][3]. It uses autonomous AI agents to hypothesize and test new treatments more efficiently than traditional methods ^[1][2].

The platform helps researchers navigate complex data to identify potential therapeutic candidates ^[2]. By automating various stages of the workflow, the companies expect to accelerate the development of new medicines ^[3]. Chugai is deploying these agents across its drug discovery operations ^[3].